18th euretina congress [september’18]
Our team members travelled to the European Society of Retina Specialists (EURETINA) in Vienna, 20-23 September, to present our latest products to make eye hospitals more efficient using Artificial Intelligence (AI). Stay tuned if you want to learn more about how AI is going to change the life of many eye care professionals in the near future.
Retinai at the Nvidia inception awards [september’18]
RetinAI is honoured to be one of the 10 selected projects to attend the GTC Europe Inception Awards NVIDIA, taking place in Munich between 9-11th October 2018. Hundreds of applications, 70 teams in the pitching semi-finals and only 10 teams in the final.
Next step will be to compete live at the GTC to get a chance to win $100.000 and a NVIDIA DGX Workstation!
RetinAI AT MICCAI’18 LABELS [September’18]
RetinAI participated in this year's edition of the annual International Conference on Medical Image Computing & Computer Assisted (MICCAI) in Granada, Spain, held on September 16-20.
This year was the first time we sponsored the Large-Scale Annotation of Biomedical data and Expert Label Synthesis (LABELS) workshop at the event, offering a price to the winner of the competition for the best paper:
'Deep Learning Retinal Vessel Segmentation From a Single Annotated Example: An Application of Cyclic Generative Adversarial Neural Networks'
by Praneeth Sadda, John A. Onofrey, and Xenophon Papademetris.
welcome to the new RetinAi [September'18]
There's nothing permanent except change -- Heraclitus. We are incredibly pleased to announce our new logo at RetinAI! This new image reflects our values, strengths and willingness to connect the anatomical and digital worlds to provide a better healthcare for the patient.
124e International congress de la SFO [May'18]
RetinAI had the pleasure to present in the 124e Congrès International de la Société Française d'Ophthalmologie in the session: 'L'impact de l'intelligence artificielle dans la santé visuelle', organised by Optic 2000 in Paris! Wonderful day presenting how AI and machine learning are changing the current paradigm of screening and monitoring of eye diseases.
Bilan Magazine top50 startups in which to invest 2018
RetinAI has been selected as one of the TOP50 Swiss startups in which to invest by the Bilan Magazine. The committee of experts evaluated the progress and projection of hundreds of startups from the Swiss ecosystem and selected the 50 most promising technologies for 2018! Congratulations to the team for this great success. Link
Phase iii [december'17]
Early detection of eye diseases is key for effective treatment to reduce the onset of blindness. However, the patient’s journey to diagnosis is often long and involves many challenges. Venture Kick just awarded RetinAI with 130'000.- CHF to make eye care accessible and affordable to everyone via artificial intelligence. Link
5th international congress oct angiography [December'17]
RetinAI will be presenting the latest company's developments in this year's edition of the 5th International Congress on OCT Angiography in Rome, on the 15-16th December. Don't forget to come to our session: Unleashing the potential of longitudinal image analysis in Optical Coherence Tomography.
NVIDIA GTC munich 2017 [october'17]
RetinAI held a presentation during the last edition of the Nvidia GTC Europe in Munich, covering how ophthalmology is changing with Machine Learning. Stefanos Apostolopoulos (Technical Director) and Dr. Sandro De Zanet (Scientific Director) presented the efforts the company is doing to improve medical eye care around the world.
5th MedTech & Digital Health Forum BASEL [OCTOBER'17]
EURETINA 2017 + MICCAI 2017 [august'17]
RetinAI is getting ready for a September full of conferences and events! September 7-10th we will be in the 17th EURETINA Congress in Barcelona, followed by 4 days in MICCAI'2017 in Quebec. In Canada we will present our work on automatic segmentation of pathological retinal layers and participate in this year's edition of the RETOUCH challenge.
ARVO 2017, Baltimore [May'17]
Our team members travelled to the American Research in Vision and Ophthalmology (ARVO) conference 2017, in Baltimore, to present their products in the field of OCT image analisys and Fundus Imaging.